Intellectual Ventures founder and CEO Nathan Myhrvold illuminates why people and the planet need every source of reliable, carbon-free energy we can get.
Read MoreInsights
Building on a decade of success, IV is pleased to announce that Global Good projects have transitioned to the Bill & Melinda Gates Foundation and Gates Ventures.
Read MoreInsights
Global Good is helping families prepare meals with cleaner, more efficient cooking by embedding technology into Jet Flame Cookstove.
Read MoreInsights
Global Good recently donated three INCUDIGIT-SV 30 biological culture incubators to the Governor’s office of Lagos State.
Read MoreInsights
Global Good recently conducted a World Cancer Day 2019 webinar called Artificial Intelligence for Identifying Cervical Precancer, which explores how a new Automated Visual Evaluation (AVE) technique will potentially increase access to quality cervical cancer screening worldwide.
Read MorePress Releases
New patent licensing program allows select software and application technology services companies greater access to IV’s vast patent portfolio.
Read MorePress Releases
Mangata Networks to Provide Affordable High Capacity 5G Over Satellite Global Solutions
Read MorePress Releases
IP industry veteran to lead commercialization strategy and execution, business development.
Read MorePress Releases
The new patent licensing program will allow select companies in the IoT space access IV’s unparalleled patent portfolio.
Read MorePublications
With partners, Global Good is redesigning the window and door to keep deadly mosquitoes out of African homes.
Read MorePublications
Autoscope was tested in the Iquitos region of Peru in 2016 at two peripheral health facilities, with routine microscopy and PCR as reference standards. The main outcome measures include sensitivity and specificity of diagnosis of malaria from Giemsa-stained blood films, using PCR as reference.
Read MorePublications
Microbiological culture remains the most sensitive method for detecting viable and infectious bacteria, but these methods often require at least 24 hours to visibly identify bacterial growth.
Read MorePublications
Here, we review the principles underpinning lateral flow assays and the historical evolution of theory to predict their performance.
Read MoreMedia Coverage
The New York Times
The New York Times calls Nathan Myhrvold, IV Founder and CEO, “One of the first people to realize the commercial potential of metamaterials…” Learn more about this exciting, emerging space that IV has been instrumental in for well over a decade.
Read MoreMedia Coverage
GeekWire
IV spinout Echodyne recently teamed up with NASA to prove drones can fly autonomously in crowded airspace.
Read MoreMedia Coverage
The New York Times
Nathan Myhrvold, CEO and Founder, discusses the science and his process behind his snowflake photography to Kenneth Chang.
Read MoreMedia Coverage
The Wall Street Journal
IV spinout Evolv Technology is combining with a SPAC to go public in a deal that values the crowd-safety firm at about $1.7 billion.
Read More